You are viewing: North America Pharmaceutical Drying Equipment Market analysis

The North America Pharmaceutical Drying Equipment Market was valued at $1485.3 Million in 2024 and projected to reach to $2073 Million by 2029, representing a compound annual growth rate of 6.9%. The North America pharmaceutical drying equipment market is poised for steady growth, expanding from $1,485.3 million in 2024 to $2,073.0 million by 2029 at a 6.9% CAGR.

North America Pharmaceutical Drying Equipment Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Pharmaceutical Drying Equipment Market Trends and Insights

  • North America's robust pharmaceutical manufacturing infrastructure, stringent regulatory requirements, and significant investment in biopharmaceutical production drive demand for advanced drying technologies.
  • The region's established presence of major pharmaceutical manufacturers and contract development and manufacturing organizations (CDMOs) positions North America as a critical market for specialized drying equipment. Growth in North America is fueled by increasing adoption of freeze-drying and spray-drying technologies for biologics, vaccines, and complex drug formulations.
  • North America's emphasis on quality control, process efficiency, and compliance with FDA and Health Canada standards accelerates equipment modernization and replacement cycles.
  • The region's expanding capacity for personalized medicine and small-batch manufacturing further supports market expansion through 2029..

Key Market Statistics

  • CAGR (2024-2029) 6.9% CAGR
  • Market Size, 2024 ~USD 1485.3 Million
  • Forecast, 2029 ~USD 2073 Million
  • Geography North America

North America Pharmaceutical Drying Equipment Market Overview

Market Leadership Position :

North America commands a significant share of the global pharmaceutical drying equipment market, driven by the region's advanced manufacturing capabilities and dominance of major pharmaceutical and biopharmaceutical companies headquartered in the US and Canada.

Regulatory Excellence Driving Innovation :

Stringent FDA and Health Canada regulations mandate cutting-edge drying technologies for pharmaceutical production, compelling manufacturers to invest in state-of-the-art equipment that meets the highest quality and safety standards.

Biopharmaceutical Expansion :

Significant growth in biologics, monoclonal antibodies, and vaccine production across North America is accelerating demand for specialized drying equipment capable of handling sensitive biopharmaceutical formulations.

Sustained Capital Investment :

Continuous investment in pharmaceutical manufacturing infrastructure modernization and facility expansions across the US and Canada supports robust demand for advanced drying technologies through 2029.

North America Pharmaceutical Drying Equipment Market Dynamics

  • This growth trajectory reflects the region's commitment to maintaining manufacturing excellence and regulatory compliance in an increasingly complex pharmaceutical landscape.
  • The US market dominates the region, supported by a dense concentration of pharmaceutical manufacturers and robust R&D investments. Key growth drivers include the accelerating shift toward biopharmaceutical production, increased adoption of continuous manufacturing processes, and heightened focus on product quality and safety.
  • North American manufacturers are increasingly adopting advanced drying technologies such as freeze-drying, spray-drying, and fluid bed drying to meet evolving regulatory requirements and improve operational efficiency.
  • Strategic investments in facility upgrades and technology modernization will continue to fuel market expansion through the forecast period..

Related Ecosystem

Key Takeaways

  • North America's pharmaceutical drying equipment market will grow from $1,485.3M (2024) to $2,073.0M (2029) at a 6.9% CAGR.
  • North America's stringent regulatory environment and advanced manufacturing standards drive continuous equipment upgrades and technology adoption.
  • Biopharmaceutical and vaccine production expansion in North America creates sustained demand for freeze-drying and spray-drying equipment.
  • North America's concentration of major pharmaceutical manufacturers and CDMOs positions the region as a key market for specialized drying solutions.

Pharmaceutical Drying Equipment Market Report Scope

Report Metric Details
Base Year 2024
Fastest Growing Segment FREEZE DRYERS (Type)
Forecast Period 2024-2029
Growth Rate CAGR of 7.1% from 2024 to 2029
Largest Segment PHARMACEUTICAL AND BIOTECH COMPANIES (End User)
Market Size Base Year (Billions) ~USD 5.81 (2024)
Revenue Forecast (Billions) ~USD 8.18 (2029)
Segments Covered Type, Scale Of Operation, End User

North America Pharmaceutical Drying Equipment Market Report Segmentation

3 segment dimensions are covered across the global market.

By Type

  • Fluidized Bed Dryers
  • Freeze Dryers
  • Other Dryers
  • Spray Dryers
  • Vacuum Dryers

By Scale Of Operation

  • Industrial-Scale Equipment
  • Laboratory-Scale Equipment
  • Pilot-Scale Equipment

By End User

  • Contract Development And Manufacturing Organizations
  • Pharmaceutical And Biotech Companies
  • Research Academies And Universities

Target Audience

  • Pharmaceutical Manufacturers : North American pharmaceutical companies require detailed market intelligence on drying equipment innovations and regulatory requirements to optimize production efficiency and maintain competitive advantage in a highly regulated environment.
  • Equipment Suppliers & OEMs : Drying equipment manufacturers need regional market data to identify growth opportunities, understand customer requirements, and develop products tailored to North American regulatory standards and manufacturing practices.
  • Biopharmaceutical Companies : Biotech firms expanding into North America require insights on specialized drying technologies for biologics production, regulatory pathways, and equipment vendors to support facility development and scale-up operations.
  • Investment & Private Equity Firms : Investors evaluating pharmaceutical manufacturing assets and equipment suppliers need regional market forecasts and growth drivers to assess investment opportunities and portfolio company performance in North America.
  • Regulatory & Compliance Consultants : Consultants advising pharmaceutical companies on regulatory compliance and manufacturing best practices require market data on equipment standards, FDA requirements, and industry trends specific to North America.

North America vs. other regions

HowNorth America compares to the other 3 regional blocs covered in this market.

Europe
~USD 2416.6 Million · 6.3% wtd CAGR ·
Asia Pacific
~USD 3046.2 Million · 8.4% wtd CAGR ·
Latin America
~USD 550.9 Million · 5.7% wtd CAGR ·
Middle East & Africa
~USD 96.7 Million · 4.3% wtd CAGR ·

Countries within North America - compare and drill down

Country2025 size (native)
USUSD 676.69 Million
CanadaUSD 72.94 Million

Country market size visualization

US
USD 676.69 Million
Canada
USD 72.94 Million

Reasons to Buy this Report

  • Regional Market Segmentation : Gain detailed insights specific to North America's pharmaceutical drying equipment landscape, including country-level breakdowns for the US and Canada to identify regional opportunities and competitive dynamics.
  • Regulatory Compliance Intelligence : Understand how FDA and Health Canada regulations shape equipment specifications and purchasing decisions, enabling better alignment with North American market requirements and compliance standards.
  • Biopharmaceutical Growth Tracking : Access data on the expanding biologics and vaccine production sectors driving demand for specialized drying technologies, with forecasts through 2029 to support strategic planning.
  • Competitive Landscape Analysis : Identify key manufacturers and technology leaders operating in North America, understand their market positioning, and benchmark against regional competitors to inform business strategy.
  • Investment Decision Support : Leverage comprehensive market sizing and growth projections to support capital allocation decisions, facility expansion plans, and technology investment priorities in the North American market.

Frequently asked questions

What is the market size of pharmaceutical drying equipment in North America?

North America's pharmaceutical drying equipment market is estimated at $1,485.3 million in 2024 and is forecast to reach $2,073.0 million by 2029.

What is the growth rate for pharmaceutical drying equipment in North America?

North America's pharmaceutical drying equipment market is projected to grow at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2029.

What factors drive growth in North America's pharmaceutical drying equipment market?

North America's market growth is driven by increased biopharmaceutical production, vaccine manufacturing expansion, stringent FDA and Health Canada regulations, and the adoption of advanced freeze-drying and spray-drying technologies.

Which drying technologies are most in demand in North America?

Freeze-drying and spray-drying technologies are the most in-demand in North America, particularly for biologics, vaccines, and complex pharmaceutical formulations requiring high precision and regulatory compliance.

How does North America's regulatory environment impact the drying equipment market?

North America's stringent FDA and Health Canada regulations mandate advanced quality control, process validation, and equipment compliance, driving continuous modernization and replacement of drying equipment across the region.

RESEARCH METHODOLOGY

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study , International Diabetes Federation (IDF), and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global pharmaceutical drying equipment market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the pharmaceutical drying equipment market. The primary sources from the demand side include pharmaceutical, biopharmaceutical companies, contract development and manufacturing organizations, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

*C-level primaries include CEOs, CFOs, COOs, and VPs.

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global pharmaceutical drying equipment market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global pharmaceutical drying equipment market was split into various segments and sub-segments based on:

  • List of major players operating in the products market at the regional and/or country level
  • Product mapping of various pharmaceutical drying equipment manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from pain management devices(or the nearest reported business unit/product category)
  • Revenue mapping of major players to cover at least 70-75% of the global market share as of 2023
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global point-of-care  diagnostics market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Market Size Estimation (Bottom Up approach & Top down approach)

Data Triangulation

After arriving at the overall size of the global pharmaceutical drying equipment market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Pharmaceutical drying equipment is used to remove solvents, such as water, from drug formulations through the application of heat. This process ensures the stability and efficacy of the final product by preventing chemical and microbiological deterioration. Common methods include air drying, vacuum drying, freeze-drying, and spray drying. These methods are crucial in both research and large-scale manufacturing to produce dry solid masses or powders, maintaining the quality and safety of active pharmaceutical ingredients (APIs).

Stakeholders

  • Pharmaceutical drying equipment Manufacturers
  • Freeze-drying/lyophilization equipment vendors/service providers
  • Research and consulting firms
  • Venture capitalists
  • Government agencies
  • Raw material suppliers
  • Regulatory bodies
  • Commercial research & development (R&D) institutions and financial institutions
  • Importers and exporters of pharmaceutical drying equipment
  • Traders, distributors, and suppliers
  • Government and research organizations
  • Trade associations and industry bodies

Report Objectives

  • To define, describe, and forecast the pharmaceutical drying equipment market based on type, scale of operation, end user, and region.
  • To forecast the market size based on five key regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, porter’s five forces, patent analysis, key stakeholders and buying criteria, and conference and events.
  • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall pharmaceutical drying equipment market.
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders.
  • To strategically profile key players in the pharmaceutical drying equipment market and comprehensively analyze their core competencies.
  • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall pharmaceutical drying equipment market.
  • To benchmark players within the market using the proprietary “Competitive Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
  • To analyze the generative AI  impact on the pharmaceutical drying equipment market

Get the Full Pharmaceutical Drying Equipment Market Report

Full forecast, segment splits, and company analysis for all Pharmaceutical Drying Equipment Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status